Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...

The US Food and Drug Administration (FDA) announces new regulatory guidelines for future COVID-19 vaccines and booster shots.

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.

The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...

Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...

COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major Trump administration policy shift.

The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over ...

The Food and Drug Administration (FDA) will require more evidence for what top officials describe as the uniquely American ...

Covid-19 booster jabs will be limited to people over 65 or those at higher risk of serious illness, under new US government rules.

The U.S. Food and Drug Administration is changing the way it approves COVID-19 vaccines for Americans — a move that will ...

FDA officials outlined new restrictions for COVID-19 vaccine approvals in the United States that could limit their use among ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.